Back
Also listed as
CMXHF
OTC
Day Range
$24.50
$25.31
52-Week Range
$22.83
$44.86
Volume
48,668
50D / 200D Avg
$27.97
/
$33.31
Prev Close
$23.95
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 32.0 | 0.4 |
| P/B | 5.0 | 2.9 |
| ROE % | 16.4 | 3.7 |
| Net Margin % | 19.5 | 3.8 |
| Rev Growth 5Y % | 10.7 | 10.0 |
| D/E | 0.6 | 0.2 |
Key Takeaways
Revenue grew 10.73% annually over 5 years — strong growth
ROE of 16.36% — decent returns on equity
Net margin of 19.46% shows strong profitability
Generating 2.54B in free cash flow
P/E of 32.02 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.47%
Growth
Revenue Growth (5Y)
10.73%
Revenue (1Y)4.26%
Earnings (1Y)13.63%
FCF Growth (3Y)67.29%
Quality
Return on Equity
16.36%
ROIC7.20%
Net Margin19.46%
Op. Margin19.18%
Safety
Debt / Equity
0.59
Current Ratio2.46
Interest Coverage6.51
Valuation
P/E Ratio
32.02
P/B Ratio4.97
EV/EBITDA35.64
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.26% | Revenue Growth (3Y) | 8.22% |
| Earnings Growth (1Y) | 13.63% | Earnings Growth (3Y) | 16.97% |
| Revenue Growth (5Y) | 10.73% | Earnings Growth (5Y) | 13.91% |
| Profitability | |||
| Revenue (TTM) | 15.43B | Net Income (TTM) | 3.00B |
| ROE | 16.36% | ROA | 7.62% |
| Gross Margin | 51.53% | Operating Margin | 19.18% |
| Net Margin | 19.46% | Free Cash Flow (TTM) | 2.54B |
| ROIC | 7.20% | FCF Growth (3Y) | 67.29% |
| Safety | |||
| Debt / Equity | 0.59 | Current Ratio | 2.46 |
| Interest Coverage | 6.51 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 32.02 | P/B Ratio | 4.97 |
| P/S Ratio | 6.23 | PEG Ratio | 3.83 |
| EV/EBITDA | 35.64 | Dividend Yield | 0.01% |
| Market Cap | 96.11B | Enterprise Value | 105.45B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 15.43B | 14.80B | 13.17B | 10.49B | 10.27B |
| Net Income | 3.00B | 2.64B | 2.19B | 2.25B | 1.78B |
| EPS (Diluted) | 0.39 | 0.34 | 0.43 | 0.30 | 0.33 |
| Gross Profit | 7.95B | 7.56B | 6.71B | 5.66B | 5.74B |
| Operating Income | 2.96B | 3.81B | 2.90B | 2.92B | 2.59B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 39.40B | 38.02B | 36.23B | 28.35B | 13.63B |
| Total Liabilities | 18.00B | 18.62B | 18.41B | 13.77B | 7.34B |
| Shareholders' Equity | 19.34B | 17.36B | 15.79B | 14.58B | 6.29B |
| Total Debt | 11.50B | 12.18B | 12.23B | 9.66B | 4.36B |
| Cash & Equivalents | 2.16B | 1.66B | 1.55B | 10.44B | 1.36B |
| Current Assets | 11.85B | 10.77B | 9.26B | 16.46B | 5.55B |
| Current Liabilities | 4.81B | 4.95B | 4.61B | 7.11B | 2.33B |